DUBLIN, December 09, 2021– (COMMERCIAL THREAD)–The “Oral Transmucosal Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2021-2031” the report was added to ResearchAndMarkets.com offer.
This Global Oral Transmucosal Drugs Market report studies the past as well as current growth trends and opportunities to gain valuable insights into market indicators during the forecast period 2021 to 2031. The report provides revenue of the global oral transmucosal drugs market for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global oral transmucosal drugs market during the forecast period.
The report explores the competitive landscape of the global oral transmucosal drugs market. Major players operating in the global oral transmucosal drugs market have been identified, and each of them has been profiled to distinguish business attributes. Company overview, financial standing, recent developments, and SWOT are some of the attributes of the global Oral Transmucosal Drugs Market players that have been featured in this report.
Answers to key questions
-
What are the main drivers, constraints and opportunities in the market?
-
What will be the annual growth of the global oral transmucosal drugs market between 2021 and 2031?
-
What are the revenue share projections of key segments of the global oral transmucosal drugs market during the forecast period?
-
Will North America continue to be the most profitable market for oral transmucosal drugs?
-
What factors are predicted to restrain the global oral transmucosal drugs market during the forecast period?
-
Who are the leading companies in the global oral transmucosal drugs market?
Key topics covered
1. Preface
1.1. Definition and scope of the market
1.2. Market segmentation
1.3. Key research objectives
1.4. Research Highlights
2. Hypotheses and research methodology
3. Executive Summary: Global Oral Transmucosal Drugs Market
4.1. introduction
4.2. Overview
4.3. Market dynamics
4.4. Global Oral Transmucosal Drugs Market Analysis and Forecast, 2017-2031
5. Key information
5.1. Main mergers and acquisitions
5.2. Impact of the COVID-19 pandemic on the industry (value chain and impact in the short / medium / long term)
5.3. Top 3 players operating in the market
5.4. Clinical trials and pipeline analysis
5.5. SWOT Analysis Of Oral Transmucosal Drugs Market
6. Global Oral Transmucosal Drugs Market Analysis and Forecast, By Type
6.1. Introduction & Definition
6.2. Main findings / developments
6.3. Market value forecast, by type, 2017-2031
6.4. Market attractiveness analysis, by type
7. Global Oral Transmucosal Drugs Market Analysis and Forecast, By Penetration
7.1. Introduction & Definition
7.2. Main findings / developments
7.3. Market value forecast, by penetration, 2017-2031
7.4. Analysis of market attractiveness, by way of penetration
8. Global Oral Transmucosal Drugs Market Analysis and Forecast, By Distribution Channel
8.1. Introduction & Definition
8.2. Main findings / developments
8.3. Market value forecast, by distribution channel, 2017-2031
8.4. Market attractiveness analysis, by distribution channel
9. Global Oral Transmucosal Drugs Market Analysis and Forecast, by Indication
9.1. Introduction & Definition
9.2. Main findings / developments
9.3. Market value forecast, by indication, 2017-2031
9.4. Market attractiveness analysis, by indication
10. Global Oral Transmucosal Drugs Market Analysis and Forecast, by Region
10.1. Main conclusions
10.2. Market value forecast, by region
10.3. Market attractiveness analysis, by country / region
11. North America Oral Transmucosal Drugs Market Analysis and Forecast
12. Europe Oral Transmucosal Drugs Market Analysis and Forecast
13. Asia-Pacific Oral Transmucosal Drugs Market Analysis and Forecast
14. Latin America Oral Transmucosal Drugs Market Analysis and Forecast
15. Middle East & Africa Oral Transmucosal Drugs Market Analysis and Forecast
16. Competition landscape
16.1. Market share analysis, by company, 2020
16.2. Company Profiles
16.2.1. LTS Lohmann Therapie-Systeme AG
16.2.2. Soligenix
16.2.3. ZIM Laboratories Limited
16.2.4. Pharmaceutical Access, Inc.
16.2.5. CL Pharm
16.2.6. Seoul Pharmaceutical
16.2.7. Pharmaceutical cure
16.2.8. Aquestive Therapeutics, Inc.
16.2.9. Solvay SA
16.2.10. NAL Pharma
16.2.11. IntelGenx Corp.
16.2.12. Izun Pharmaceuticals
16.2.13. Eisai Co. Ltd.
16.2.14. AstraZeneca
16.2.15. Otsuka Pharmaceutical Co. Ltd.
16.2.16. Pfizer, Inc.
16.2.17. Teva Pharmaceutical Industries Ltd.
16.2.18. GlaxoSmithKline plc
16.2.19. Mylan NV
16.2.20. Bristol-Myers Squibb Company
For more information on this report, visit https://www.researchandmarkets.com/r/o84lq9
See the source version on businesswire.com: https://www.businesswire.com/news/home/20211209005524/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Director
[email protected]esearchandmarkets.com
For EST office hours, call 1-917-300-0470
For USA / CAN call toll free 1-800-526-8630
For GMT office hours, call + 353-1-416-8900
